Early Transition Metal‐Based Antitumor Complexes
Chemistry – An Asian Journal · 2026-01 · 21 (1)
DOI: 10.1002/asia.70552 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemistry – An Asian Journal, online erschienen am 14.01.2026. Verfasst von Xinyi Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Changzhou University, Changzhou, P. R. China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Transition Elements, Coordination Complexes, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 230 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Cancer is a major disease that seriously threatens human health worldwide. The development of highly effective and low toxicity anticancer drugs has always been a research hotspot. Transition metal complexes, as antitumor drugs, offer multiple advantages, including the synergistic effect of targeting multiple sites, which reduces drug resistance, strong structural adjustability for optimizing the efficacy of the medicine, unique photodynamic/photothermal therapy capabilities, and the ability to integrate diagnosis and treatment. Early transition metals refer to the d‐block metal elements from Group IIIB to Group VIIB in the periodic table. In recent years, antitumor complexes of early transition metals have received extensive attention due to their unique mechanisms of action and potential therapeutic effects. In this review, we summarize the latest advancements in the anticancer effects of metal complexes of Ti, V, Cr, Mn, Mo, Tc, and Re, which represent a new type of anticancer drug with multiple mechanisms, and are expected to provide more effective solutions for precise tumor treatment. With the deepening of research and the development of technology, early transition metal‐based drugs may play a more important role in precision medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Changzhou University, Changzhou, P. R. China.
- School of Life Sciences, Jiangsu Normal University, Xuzhou, P. R. China.
- School of Medical and Health Engineering, Changzhou University, Changzhou, P. R. China.
- Changzhou Institute of Advanced Materials, Beijing University of Chemical Technology, Changzhou, P. R. China.
ORCID-Profile: Jianhao Wang, Yang Bai
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, X., Fu, X., Pu, X., Ju, S., Zhao, Y., Zhang, C., Wang, J., Zhu, Q., Qiu, L., & Bai, Y. (2026). Early Transition Metal‐Based Antitumor Complexes. Chemistry – An Asian Journal, 21(1). https://doi.org/10.1002/asia.70552
Vancouver
Li X, Fu X, Pu X, Ju S, Zhao Y, Zhang C, et al. Early Transition Metal‐Based Antitumor Complexes. Chemistry – An Asian Journal. 2026;21(1). doi:10.1002/asia.70552
BibTeX
@article{Li2026,
author = {Li, Xinyi and Fu, Xuanqi and Pu, Xiaojie and Ju, Siying and Zhao, Yufeng and Zhang, Can and Wang, Jianhao and Zhu, Qibai and Qiu, Lin and Bai, Yang},
title = {Early Transition Metal‐Based Antitumor Complexes},
journal = {Chemistry – An Asian Journal},
year = {2026},
volume = {21},
number = {1},
doi = {10.1002/asia.70552}
}
EUVIMED